2021
DOI: 10.1002/adhm.202101085
|View full text |Cite
|
Sign up to set email alerts
|

Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies

Abstract: One of the obstacles limiting progress in the development of effective cancer therapies is the shortage of preclinical models that capture the dynamic nature of tumor microenvironments. Interstitial flow strongly impacts tumor response to chemotherapy; however, conventional in vitro cancer models largely disregard this key feature. Here, a proof of principle microfluidic platform for the generation of large arrays of breast tumor spheroids that are grown under close-to-physiological flow in a biomimetic hydrog… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
60
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 62 publications
(68 citation statements)
references
References 79 publications
1
60
0
Order By: Relevance
“…The experimental MF device contained 200 MCTSs in the microwells that were organized in four parallel rows ( Figure 4A ). The microwells were connected to a common channel used to supply cell culture medium and drug treatment [for more details on fabrication, MCTS formation, and cell staining protocols see Supplementary Material and ( Chen et al, 2021 ; Prince et al, 2021 )]. The cell suspension occupied 100% of the microwells in the form of cell-laden droplets; MCTSs formed within 72 h of cell culture.…”
Section: Resultsmentioning
confidence: 99%
“…The experimental MF device contained 200 MCTSs in the microwells that were organized in four parallel rows ( Figure 4A ). The microwells were connected to a common channel used to supply cell culture medium and drug treatment [for more details on fabrication, MCTS formation, and cell staining protocols see Supplementary Material and ( Chen et al, 2021 ; Prince et al, 2021 )]. The cell suspension occupied 100% of the microwells in the form of cell-laden droplets; MCTSs formed within 72 h of cell culture.…”
Section: Resultsmentioning
confidence: 99%
“…Our group has developed various MF strategies for cell encapsulation, which utilized both hydrodynamic junctions , and hydrodynamic traps. Emulsification using hydrodynamic junctions enables the generation of cell-laden droplets with a high frequency. Furthermore, several MF droplet generators can be combined to work in parallel.…”
Section: Cell Encapsulation In Dropletsmentioning
confidence: 99%
“…Microgels generated by droplet MFs were used for drug delivery and the delivery of vascular endothelial growth factor to ischemic muscle sites . Recently, we developed MF spheroid-on-a-chip platforms for the generation of multicellular spheroids and organoids, which were utilized for coculturing cells, screening active ingredients, and modeling drug delivery to multicellular spheroids. …”
Section: Introductionmentioning
confidence: 99%
“…Prince et al developed a device that is able to form tumour spheroids uniformly under close-to-physiological flow conditions within a microfluidic device. 38 The use of flow in this device provides longer culture durations of spheroid culture, model of dynamic drug conditions, and sequential testing of drugs, mimicking clinical pharmacokinetics.…”
Section: Microfluidic Devicesmentioning
confidence: 99%